Antecedents of renal disease in Aborigines

Nephrology

Volumn 9, Issue SUPPL. 4, 2004, Pages

  Thomas, Mark ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Aborigine; Birth weight; Diabetes; End stage renal disease; Obesity; Proteinuria

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ABORIGINE; ALCOHOL CONSUMPTION; AUSTRALIA; BIOACCUMULATION; BLOOD PRESSURE MONITORING; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DEMOGRAPHY; DIABETES CONTROL; DISEASE CONTROL; DISEASE COURSE; EPIDEMIC; ETHNOLOGY; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HUMAN; KIDNEY DISEASE; PREDICTION; PRIORITY JOURNAL; PROTEINURIA; QUALITY OF LIFE; RISK FACTOR; SEX DIFFERENCE; SMOKING;

AUSTRALIA; HUMANS; KIDNEY FAILURE, CHRONIC; OCEANIC ANCESTRY GROUP; PROTEINURIA; RISK FACTORS;

EID: 12344314074     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2004.00344.x     Document Type: Conference Paper

References (19)

1. Spencer JL, Silva DT, Snelling P, Hoy WE. An epidemic of renal failure among Australian Aboriginals. Med. J. Aust. 1998; 168: 537-41.
2. Seymour AE. Glomerular disease in whites versus Australian aboriginals: 'last of a race in ruin' (G.K. Chesterton). Nephrol. Dial. Transplant. 1995; 10: 769-70.
3. Young RJ, Hoy WE, Kincaid-Smith P, Seymour AE, Bertram JF. Glomerular size and glomerulosclerosis in Australian Aborigines. Am. J. Kidney Dis. 2000; 36: 481-9.
4. Hughson M, Farris AB 3rd, Douglas-Denton R, Hoy WE, Bertram JF. Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int. 2003; 63: 2113-22.
5. Baldwin DN, Spencer JL, Jeffries-Stokes CA. Carbohydrate intolerance and kidney stones in children in the Goldfields. J. Paediatr. Child Health 2003; 39: 381-5.
6. Brameld K, Holman D, Thomas M, Bass J. Use of a state data bank to measure incidence and prevalence of a chronic disease: end-stage renal failure. Am. J. Kidney Dis. 1999; 34: 1033-9.
7. McDonald SP, Russ GR. Incident ESRD rates for Aborigines and non-indiginous Australians in the late 1990s. In: Russ GR, ed. ANZDATA Registry Report 2001, Chapter 11. Adelaide, SA: Australia and New Zealand Dialysis and Transplant Registry, 2001: 95-97.
8. Australian Bureau of Statistics. Experimental Estimates of the Aboriginal and Torres Strait Islander Population, Australia, 1998. Canberra, ABS Cat. no. 1998, 3230.0.
9. Cass A, Gillin AG, Horvath JS. End-stage renal disease in aboriginals in New South Wales: a very different picture to the Northern Territory. Med. J. Aust. 1999; 171: 407-10.
10. Hoy WE, Mathews JD, McCredie DA et al. The multidimensional nature of renal disease: rates and associations of albuminuria in an Australian aboriginal community. Kidney Int. 1998; 54: 1296-304.
11. Gracey M, Spargo RM, Smith P et al. Risk factors for ill-health in a remote desert-dwelling aboriginal community in Western Australia. Aust. NZ J. Med. 1996; 26: 171-9.
12. McDermott R, Rowley KG, Lee AJ, Knight S, O'Dea K. Increase in prevalence of obesity and diabetes and decrease in plasma cholesterol in a central Australian aboriginal community. Med. J. Aust. 2000; 172: 480-4.
13. Beilin LJ, Puddey IB, Burke V. Lifestyle and hypertension. Am. J. Hypertens 1999; 12: 934-45.
14. Stengel B, Tarver-Carr ME, Powe NR, Eberhardt MS, Brancati FL. Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology 2003; 14: 479-87.
15. Cass A, Cunningham J, Snelling P, Wang Z, Hoy W. Exploring the pathways leading from disadvantage to end-stage renal disease for indigenous Australians. Soc. Sci. Med. 2004; 58: 767-85.
16. Hoy WE, Wang Z, Baker PR, Kelly AM. Reduction in natural death and renal failure from a systematic screening and treatment program in an Australian Aboriginal community. Kidney Int. Suppl. 2003; S66-73.
17. Baker PRA, Wang Z, Glaziou P, Hoy W. Cost-savings of a treatment program to reduce renal failure in Australian Aborigines. 33rd Annual Meeting of the American Society of Nephrology. J. Am. Soc. Nephrol. 2000; 11: A0745, P.138A.317.
18. Hoy WE, Konsdalsamy Chennavesakan S. Resurgence of deaths and end-stage renal disease in a high risk Aboriginal Australian community. 39th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology. Nephrology 2003; 8: Abs P19, A59.
19. Nakao N, Yoshimura A, Morita H, Takada M, Kayano T, Ideura T. Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial. Lancet 2003; 361: 117-24.